Cite

HARVARD Citation

    Turner, J. et al. (2016). Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors. Journal of hematology & oncology. 9 (1), pp. 1-11. [Online]. 
  
Back to record